BACKGROUND: The Self Governing Region of Cantabria within the state of Spain has a population of 541,885, of which 107,787 individuals are aged from 18 months to 19 years. A vaccination campaign against meningitis was conducted in this Region in February and March, 1997. It was directed at children from the age of 18 months up to 19 years old, and included all municipal areas, achieving a coverage of more than 95%. In the following 12 months the efficacy achieved by the vaccination was 95.68% for all age groups. To help decide on the need for re-vaccination, a study of the prevalence in serum of bactericide antibodies in the vaccinated population was carried out. METHODS: in December 1997 blood samples from 414 vaccinated children were anal...
São apresentados os resultados da avaliação da vacina antimeningocócica BC de procedência cubana rea...
The new meningococcal C conjugate vaccine became available in Spain and was included in the infant v...
Texto completo: acesso restrito. p. 5541–5546To combat rising incidence of serogroup C meningococcal...
BACKGROUND: In 1997, 18.5% of the cases of Meningococcal Disease caused b serogroup C in Andalusia w...
Background: An increase in the incidence of meningococcal disease in the Region of Murcia, Spain, du...
The results of the meningococcal vaccination cnmpaign carried out in Cantabria in February-March 199...
FUNDAMENTO: En febrero-marzo de 1997 se realizó en Cantabria (Comunidad Autónoma del Estado Español ...
Background: In 1997, 18.58 of the cases of Meningoxococcacal l Disease caused b serogroup C in Andal...
BACKGROUND: This report is a systematic review of the effect, intensity and duration of the immune r...
BACKGROUND: The change in the epidemiological pattern undergone by meningococcal disease in a large ...
STUDY OBJECTIVES The objective of this study was to evaluate the effectiveness of a mass vaccination...
Bacground: The change in the epidemiological pattem undergone by meningococcal disease in a large pa...
BACKGROUND: This report is a systematic review of the effect intensity and duration of the immune re...
Bacground: On the basls of active surveillance and the monitoring of Meningococcal Disease (MD) foll...
In addition to vaccine efficacy studies, there is a pressing need to evaluate vaccine effectiveness ...
São apresentados os resultados da avaliação da vacina antimeningocócica BC de procedência cubana rea...
The new meningococcal C conjugate vaccine became available in Spain and was included in the infant v...
Texto completo: acesso restrito. p. 5541–5546To combat rising incidence of serogroup C meningococcal...
BACKGROUND: In 1997, 18.5% of the cases of Meningococcal Disease caused b serogroup C in Andalusia w...
Background: An increase in the incidence of meningococcal disease in the Region of Murcia, Spain, du...
The results of the meningococcal vaccination cnmpaign carried out in Cantabria in February-March 199...
FUNDAMENTO: En febrero-marzo de 1997 se realizó en Cantabria (Comunidad Autónoma del Estado Español ...
Background: In 1997, 18.58 of the cases of Meningoxococcacal l Disease caused b serogroup C in Andal...
BACKGROUND: This report is a systematic review of the effect, intensity and duration of the immune r...
BACKGROUND: The change in the epidemiological pattern undergone by meningococcal disease in a large ...
STUDY OBJECTIVES The objective of this study was to evaluate the effectiveness of a mass vaccination...
Bacground: The change in the epidemiological pattem undergone by meningococcal disease in a large pa...
BACKGROUND: This report is a systematic review of the effect intensity and duration of the immune re...
Bacground: On the basls of active surveillance and the monitoring of Meningococcal Disease (MD) foll...
In addition to vaccine efficacy studies, there is a pressing need to evaluate vaccine effectiveness ...
São apresentados os resultados da avaliação da vacina antimeningocócica BC de procedência cubana rea...
The new meningococcal C conjugate vaccine became available in Spain and was included in the infant v...
Texto completo: acesso restrito. p. 5541–5546To combat rising incidence of serogroup C meningococcal...